MicroRNA let-7i induced autophagy to protect T cell from apoptosis by targeting IGF1R

Biochemical and Biophysical Research Communications

Volumn 453, Issue 4, 2014, Pages 728-734

  Hou, Chunfeng ^a   Zhu, Mengzhu ^b   Sun, Min ^c   Lin, Yanliang ^d  

^a Jining First People's Hospital   (China)

^b Linyi Traditional Chinese Medical Hospital   (China)

^c JINING MEDICAL UNIVERSITY   (China)

^d SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

Author keywords

Ankylosing; Apoptosis; Autophagy; IGF1R; MicroRNA let 7i; Spondylitis

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN; MICRORNA; MICRORNA LET 7I; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE B; SMALL INTERFERING RNA; SOMATOMEDIN C RECEPTOR; UNCLASSIFIED DRUG; MIRNLET7 MICRORNA, RAT;

ANKYLOSING SPONDYLITIS; APOPTOSIS; ARTICLE; AUTOPHAGY; CELL SURVIVAL; DOWN REGULATION; HUMAN; HUMAN CELL; LUCIFERASE ASSAY; PROTEIN PHOSPHORYLATION; T LYMPHOCYTE; UPREGULATION; CELL CULTURE; DRUG EFFECTS; GENE SILENCING; GENE TARGETING; GENETICS; PATHOLOGY; PROCEDURES;

APOPTOSIS; AUTOPHAGY; CELLS, CULTURED; GENE SILENCING; GENE TARGETING; HUMANS; MICRORNAS; RECEPTOR, IGF TYPE 1; SPONDYLITIS, ANKYLOSING; T-LYMPHOCYTES;

EID: 84910020383     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2014.10.002     Document Type: Article

References (41)

1. A. Cortes, J. Hadler, and J.P. Pointon Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci Nat. Genet. 45 2013 730 738
2. D.M. Evans, C.C. Spencer, and J.J. Pointon Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility Nat. Genet. 43 2011 761 767
3. M. Ogasawara, D.H. Kono, and D.T. Yu Mimicry of human histocompatibility HLA-B27 antigens by Klebsiella pneumonia Infect. Immun. 51 1986 901 908
4. N. Arpaia, C. Campbell, X. Fan, and A.Y. Rudensky Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation Nature 504 2013 451 455
5. H. Appel, R. Maier, and J. Bleil In situ analysis of interleukin-23- and interleukin-12-positive cells in the spine of patients with ankylosing spondylitis Arthritis Rheum. 65 2013 1522 1529
6. U. Syrbe, R. Scheer, P. Wu, and J. Sieper Differential synovial Th1 cell reactivity towards Escherichia coli antigens in patients with ankylosing spondylitis and rheumatoid arthritis Ann. Rheum. Dis. 71 2012 1573 1576
7. Y. Wu, M. Ren, and R. Yang Reduced immunomodulation potential of bone marrow-derived mesenchymal stem cells induced CCR4+CCR6+ Th/Treg cell subset imbalance in ankylosing spondylitis Arthritis Res Ther. 13 2011 R29
8. K. Nistala, H. Moncrieffe, K.R. Newton, H. Varsani, P. Hunter, and L.R. Wedderburn Interleukin-17-producing T cells are enriched in the joints of children with arthritis, but have a reciprocal relationship to regulatory T cell numbers Arthritis Rheum. 58 2008 875 887
9. J. Wittmann, and H.M. Jäck MicroRNAs in rheumatoid arthritis: midget RNAs with a giant impact Ann. Rheum. Dis. 70 2011 i92 i96
10. M. Thamilarasan, D. Koczan, M. Hecker, B. Paap, and U.K. Zettl MicroRNAs in multiple sclerosis and experimental autoimmune encephalomyelitis Autoimmun. Rev. 11 2012 174 179
11. M. Matysiak, M. Fortak-Michalska, B. Szymanska, W. Orlowski, A. Jurewicz, and K. Selmaj MicroRNA-146a negatively regulates the immunoregulatory activity of bone marrow stem cells by targeting prostaglandin E2 synthase-2 J. Immunol. 190 2013 5102 5109
12. I.S. Okoye, S. Czieso, E. Ktistaki, K. Roderick, S.M. Coomes, V.S. Pelly, Y. Kannan, J. Perez-Lloret, J.L. Zhao, D. Baltimore, J. Langhorne, and M.S. Wilson Transcriptomics identified a critical role for Th2 cell-intrinsic miR-155 in mediating allergy and antihelminth immunity Proc. Natl. Acad. Sci. USA 111 2014 E3081 E3090
13. F. Liu, C.X. He, L.J. Luo, Q.L. Zou, Y.X. Zhao, R. Saini, S.F. Han, H.J. Knölker, L.S. Wang, and B.X. Ge Nuclear hormone receptor regulation of microRNAs controls innate immune responses in C. elegans PLoS Pathog. 9 2013 e1003545
14. S. Polikepahad, J.M. Knight, and A.O. Naghavi Proinflammatory role for let-7 microRNAs in experimental asthma J. Biol. Chem. 285 2010 30139 30149
15. N.S. Lai, H.C. Yu, H.C. Chen, C.L. Yu, H.B. Huang, and M.C. Lu Aberrant expression of microRNAs in T cells from patients with ankylosing spondylitis contributes to the immunopathogenesis Clin. Exp. Immunol. 173 2013 47 57
16. M.E. Segretin, A. Galeano, A. Roldán, and R. Schillaci Insulin-like growth factor-1 receptor regulation in activated human T lymphocytes Horm. Res. 59 2003 276 280
17. M.G. Brocardo, R. Schillaci, A. Galeano, M. Radrizzani, V. White, A.G. Guerrico, T.A. Santa-Coloma, and A. Roldán Early effects of insulin-like growth factor-1 in activated human T lymphocytes J. Leukoc. Biol. 70 2001 297 305
18. R. Schillaci, M.G. Brocardo, A. Galeano, and A. Roldán Downregulation of insulin-like growth factor-1 receptor (IGF-1R) expression in human T lymphocyte activation Cell. Immunol. 183 1998 157 161
19. H. Medyouf, S. Gusscott, and H. Wang High-level IGF1R expression is required for leukemia-initiating cell activity in T-ALL and is supported by Notch signaling J. Exp. Med. 208 2011 1809 1822
20. S. van der Linden, H.A. Valkenburg, and A. Cats Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria Arthritis Rheum. 27 1984 361 368
21. N.M. Alajez, W. Shi, D. Wong, M. Lenarduzzi, J. Waldron, I. Weinreb, and F.F. Liu Lin28b promotes head and neck cancer progression via modulation of the insulin-like growth factor survival pathway Oncotarget 3 2012 1641 1652
22. Y. Liu, L. Zhao, and Y. Ju A novel androstenedione derivative induces ROS-mediated autophagy and attenuates drugresistance in osteosarcoma by inhibiting macrophage migration inhibitory factor (MIF) Cell Death Dis. 5 2014 e1361
23. A. Puzik, J. Rupp, B. Tröger, W. Göpel, E. Herting, and C. Härtel Insulin-like growth factor-I regulates the neonatal immune response in infection and maturation by suppression of IFN-γ Cytokine 60 2012 369 376
24. R.S. Douglas, A.G. Gianoukakis, S. Kamat, and T.J. Smith Aberrant expression of the insulin-like growth factor-1 receptor by T cells from patients with Graves' disease may carry functional consequences for disease pathogenesis J. Immunol. 178 2007 3281 3287
25. M.D. Grounds Reasons for the degeneration of ageing skeletal muscle: a central role for IGF-1 signalling Biogerontology 3 2002 19 24
26. P.T. Walsh, and R. O'Connor The insulin-like growth factor-I receptor is regulated by CD28 and protects activated T cells from apoptosis Eur. J. Immunol. 30 2000 1010 1018
27. R. Kooijman, J.J. Lauf, A.C. Kappers, and G.T. Rijkers Insulin-like growth factor induces phosphorylation of immunoreactive insulin receptor substrate and its association with phosphatidylinositol-3 kinase in human thymocytes J. Exp. Med. 182 1995 593 597
28. R.K. Kooijman, L.E. Scholtens, G.T. Rijkers, and B.J. Zegers Differential expression of type I insulin-like growth factor receptors in different stages of human T cells Eur. J. Immunol. 25 1995 931 935
29. C. Tarn, L. Rink, E. Merkel, D. Flieder, H. Pathak, D. Koumbi, J.R. Testa, B. Eisenberg, M. von Mehren, and A.K. Godwin Insulin-like growth factor 1 receptor is a potential therapeutic target for gastrointestinal stromal tumors Proc. Natl. Acad. Sci. USA 105 2008 8387 8392
30. Y. Sekine, Y. Furuya, M. Nishii, H. Koike, H. Matsui, and K. Suzuki Simvastatin inhibits the proliferation of human prostate cancer PC-3 cells via down-regulation of the insulin-like growth factor 1 receptor Biochem. Biophys. Res. Commun. 372 2008 356 361
31. K. Suda, H. Mizuuchi, K. Sato, T. Takemoto, T. Iwasaki, and T. Mitsudomi The insulin-like growth factor 1 receptor causes acquired resistance to erlotinib in lung cancer cells with the wild-type epidermal growth factor receptor Int. J. Cancer 135 2014 1002 1006
32. J. Zou, H. Appel, M. Rudwaleit, A. Thiel, and J. Sieper Analysis of the CD8+ T cell response to the G1 domain of aggrecan in ankylosing spondylitis Ann. Rheum. Dis. 64 2005 722 729
33. N.M. Alajez, W. Shi, D. Wong, M. Lenarduzzi, J. Waldron, I. Weinreb, and F.F. Liu Lin28b promotes head and neck cancer progression via modulation of the insulin-like growth factor survival pathway Oncotarget 3 2012 1641 1652
34. D. Sun, R. Layer, A.C. Mueller, M.A. Cichewicz, M. Negishi, B.M. Paschal, and A. Dutta Regulation of several androgen-induced genes through the repression of the miR-99a/let-7c/miR-125b-2 miRNA cluster in prostate cancer cells Oncogene 33 2014 1448 1457
35. Y.L. Chen, R.H. Yuan, W.C. Yang, H.C. Hsu, and Y.M. Jeng The stem cell E3-ligase Lin-41 promotes liver cancer progression through inhibition of microRNA-mediated gene silencing J. Pathol. 229 2013 486 496
36. C. Riehle, A.R. Wende, and S. Sena Insulin receptor substrate signaling suppresses neonatal autophagy in the heart J. Clin. Invest. 123 2013 5319 5333
37. L. Al-Qusairi, I. Prokic, L. Amoasii, C. Kretz, N. Messaddeq, J.L. Mandel, and J. Laporte Lack of myotubularin (MTM1) leads to muscle hypotrophy through unbalanced regulation of the autophagy and ubiquitin-proteasome pathways FASEB J. 27 2013 3384 3394
38. N. Mizushima, B. Levine, A.M. Cuervo, and D.J. Klionsky Autophagy fights disease through cellular self-digestion Nature 451 2008 1069 1075
39. V. Deretic, T. Saitoh, and S. Akira Autophagy in infection, inflammation and immunity Nat. Rev. Immunol. 13 2013 722 737
40. T. Saitoh, N. Fujita, and M.H. Jang Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1beta production Nature 456 2008 264 268
41. F. Ciccia, A. Accardo-Palumbo, and A. Rizzo Evidence that autophagy, but not the unfolded protein response, regulates the expression of IL-23 in the gut of patients with ankylosing spondylitis and subclinical gut inflammation Ann. Rheum. Dis. 73 2014 1566 1574